Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis PatientsTheodore Mellors, Viatcheslav R. Akmaev, Johanna B. Withers et al.|Network and Systems Medicine|2020Cited by 42
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational StudyStanley Cohen, Viatcheslav R. Akmaev, Jeffrey R. Curtis et al.|Rheumatology and Therapy|2021Cited by 34
Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid ArthritisStanley Cohen, Viatcheslav R. Akmaev, Jeffrey R. Curtis et al.|Rheumatology and Therapy|2022Cited by 1
Enhancing the Accuracy of Network Medicine Through Understanding the Impact of Sample Size in Gene Co-expression NetworksJoaquim Aguirre‐Plans, Albert-Ĺaszló Barabási, Alex Jones et al.|Network and Systems Medicine|2025Cited by 1
Enhancing the accuracy of Network Medicine through understanding the impact of sample size in gene co-expression networksJoaquim Aguirre‐Plans, Albert-Ĺaszló Barabási, Alex Jones et al.|Unknown|2024Cited by 0